PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

EQT-Q4-2023-Earnings-Presentation - EQT Corporation | Presentation Nation

HomepageEQT CorporationEQT-Q4-2023-Earnings-Presentation

EQT-Q4-2023-Earnings-Presentation

EQT Corporation

Browse presentations, reports, and documents from EQT Corporation.

Tags

2023

Filter options

All (30)●
brochure (1)○
earnings (2)○
investor_presentation (9)○
presentation (18)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

EQT-Q4-2023-Earnings-Presentation by EQT Corporation.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from EQT Corporation

EQT-Announces-Transformative-Acquisition-of-Equitrans-Midstream.PDF

presentation

EQT Corporation Analyst Presentation 2016

investor_presentation

investor_presentation

Similar presentations from other companies

4_philippine_energy_project_financing

presentation

First Metro

Quantum_August_2017_55_13055

presentation

Quantum Corporation

Conduent_August_2018_137_32137

31 Pages

EQT Corporation Analyst Presentation October 2016

investor_presentation

investor_presentation

33 Pages

EQT Corporation_April_2022_94_82094

presentation

EQT Corporation_April_2024_566_100566

presentation

EQT Corporation_February_2021_870_65870

presentation

presentation

Conduent Business Services

Kala Pharmaceuticals_January_2022_931_77931

presentation

KALA BIO

Clean Harbors__2023__637_91637

presentation

Clean Harbors

Bayer AG_May_2020_171_56171

presentation

Bayer Pharmaceuticals